Neo7
Personalized Peptide Therapy
Personalized Peptide made only for YOU
Precision Molecular Solutions — Built From Your Biology
Whether you're facing advanced cancer, a complex chronic illness, or the lingering effects of post-COVID syndrome — the underlying problem is often the same: dysfunctional signaling your body can no longer self-correct.
Neo7 Bioscience uses multi-omic analysis — genomic, transcriptomic, proteomic, and immunologic (HLA) data — to design individualized peptide therapeutics that correct multiple dysfunctional pathways simultaneously. Not a protocol. Not a single-target drug. A precision strategy engineered from your molecular profile.
Who can this help?
Advanced & Treatment-Resistant Cancer. For patients who have completed chemotherapy, immunotherapy, radiation, or surgery and still face progression, resistance, or instability — Neo7 targets the upstream signaling dysfunction that allows cancer to persist.
Complex Chronic Illness. Conditions involving immune dysregulation, chronic inflammation, mitochondrial dysfunction, and overlapping diagnoses — including Lyme, mold illness, autoimmune disorders, and metabolic dysfunction — often share common signaling failures that conventional approaches treat in isolation. Neo7 addresses them as a coordinated system.
Post-COVID Syndrome. Persistent fatigue, cognitive dysfunction, immune dysregulation, and inflammatory cascades following COVID-19 reflect ongoing signaling disruption. Neo7 maps the specific molecular drivers and designs targeted correction strategies to restore functional biology.
How is Neo7 Different?
Most therapies target one mechanism at a time using static data that doesn't adapt as your biology evolves. Neo7 evaluates immune signaling, inflammatory cascades, angiogenesis, mitochondrial stress, repair pathways, and resistance networks — then designs a coordinated peptide strategy targeting 6 to 14+ dysfunctional pathways at once.
Every peptide sequence is uniquely engineered. No two are alike. This is N-of-1 precision at the molecular level.
The Hub Strategy
Think of your treatment as a wheel. Each therapy is a spoke. Neo7 is the hub.
Neo7 doesn't replace your current treatments — it strengthens the biological environment underneath them. When signaling improves, treatments work more predictably, resistance decreases, inflammation stabilizes, and recovery accelerates.
The Process
The Neo7 process takes approximately 11 weeks.
Weeks 1–5: Sample collection and deep multi-omic analysis. Weeks 5–10: Custom peptide design and cGMP-compliant manufacturing. Week 11: First administration.
During this time, your clinical team stabilizes inflammation, supports detoxification, and strengthens immune function. This is preparation — not waiting.
Disclaimer
Neo7 precision and personalized peptide therapies are investigational and developed under a physician-directed, Institutional Review Board (IRB)–governed framework. These therapies are not approved by the U.S. Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease. All peptides are manufactured through Neo7-vetted cGMP-compliant facilities and dispensed exclusively through licensed pharmacies pursuant to a valid prescription. Individual results may vary.
Interested in Thermofield therapy?
We’d love to talk with you about how this treatment can fit into your personalized care plan.